Clinical trial Recruiting at 15 sites Interventional Ages 18 and up

Comparing drug eluting balloons and stents for treating calcified nodules in coronary arteries

Official title: DEBSCAN-IVL. Drug Eluting Balloon or Drug Eluting Stent to Treat CAlcified Nodules After IntraVascular Lithotripsy.

Run by Fundación EPIC · NCT06657833 · Data updated 2026-11-12

This study is testing whether drug eluting balloons can work as well as drug eluting stents for treating calcified nodules in the coronary arteries of patients with heart conditions.

More Coronary Artery Disease trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment128 (estimated)
SponsorFundación EPIC
Academic / other
Locations15 sites (Leiden and 14 other locations)
StatusRecruiting
StartedDecember 17, 2024
Main results expectedOctober 30, 2027
Study endsOctober 30, 2027
Registry record updatedSeptember 30, 2026
Trial IDNCT06657833 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults over 18 with stable coronary artery disease or acute coronary syndromes and severe calcified lesions suitable for percutaneous coronary intervention.

Probably not a fit

Patients with life expectancy less than one year, those with left main stem lesions, or those previously treated with stents or DEB may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This international, multicenter trial investigates the effectiveness of drug eluting balloons (DEB) versus drug eluting stents (DES) in patients with calcified nodules in coronary arteries. Patients with stable coronary artery disease or acute coronary syndromes will be randomized to receive either DEB or DES after undergoing intravascular lithotripsy to modify the calcified plaque. The study aims to determine if DEB can provide similar or better outcomes in terms of lumen loss and gain compared to DES at a 6-month follow-up. The trial is designed to address the lack of data on the safety and efficacy of DEB in this specific patient population.

Why it matters

Potential benefit: If successful, this study could offer a less invasive treatment option for patients with calcified coronary lesions, potentially improving their outcomes.

How similar studies have gone: While there is some observational data on DEB performance in calcified lesions, this approach is relatively novel and lacks extensive prior testing.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Patients must meet all inclusion criteria:

* Patients \>18 years admitted for stable coronary artery disease or acute coronary syndromes and indication for percutaneous coronary intervention (PCI) and
* Severe coronary lesion with calcified nodule, confirmed with intracoronary imaging (optical coherence tomography or intravascular ultrasound) and;
* Lesion to treat in a vessel between 2.5 and 4 mm.

Exclusion Criteria:

Patients must not meet any criteria

* Inability to provide oral and written informed consent or unwillingness to come back for systematic angiographic follow-up.
* Pregnant or breastfeeding patients.
* Cardiogenic Shock or Cardiac arrest at the moment of the index procedure.
* Impossibility to maintain double antiplatelet treatment during at least 1 month.
* Life expectancy \<1 year.
* Index lesion at left main stem.
* Aorto-ostial lesion.
* Target lesion previously treated with stents or DEB.
* High thrombus burden in the target lesion (TIMI thrombus scale≥3).

Where it's running

  • Leiden University Medical Center
    Leiden, Netherlands
    Recruiting
  • Hospital Del Mar
    Barcelona, Spain
    Recruiting
  • Hospital Universitario de La Paz
    Fuencarral-El Pardo, Spain
    Recruiting
  • Hospital Universitario de Galdakao-Usansolo
    Galdakao, Spain
    Recruiting
  • Hospital Universitari de Bellvitge
    L'Hospitalet de Llobregat, Spain
    Recruiting
  • Hospital Universitario de León
    León, Spain
    Recruiting
Show 9 more locations
  • Hospital Universitario 12 de Octubre
    Madrid, Spain
    Recruiting
  • Hospital Universitario Puerta de Hierro
    Madrid, Spain
    Recruiting
  • Hospital Clínico San Carlos
    Moncloa-Aravaca, Spain
    Recruiting
  • Hospital Universitario de Navarra
    Pamplona, Spain
    Recruiting
  • Hospital General Universitario de Valencia
    Valencia, Spain
    Recruiting
  • Hospital Universitario y Politécnico La Fe
    Valencia, Spain
    Recruiting
  • Hospital Clínico Universitario de Valladolid
    Valladolid, Spain
    Recruiting
  • Hospital Universitario de Vigo
    Vigo, Spain
    Recruiting
  • Hospital Universitario Miguel Servet
    Zaragoza, Spain
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.